Three conditions have received relatively focused research attention in the CST literature: neck pain, fibromyalgia, and pregnancy-related pelvic girdle pain. Each has at least one reasonably well-designed trial, and together they show the range of what the evidence can and can't tell us.
This article looks at the key trials for each condition. The aim is a clear picture of what was studied, how many people took part, and what the researchers found — including where the results are encouraging and where they're more limited.
Neck pain: a sham-controlled trial
The most cited CST trial for neck pain was published in 2015. It enrolled 54 patients with non-specific neck pain and ran for eight weeks. What makes it notable is the control: participants in the comparison group received a sham treatment — hands-on contact with a therapist, but without the intentional quality and specific techniques of a real CST session. That's more rigorous than comparing CST against no treatment or a waiting list.
The results were statistically significant and, by the researchers' own assessment, clinically relevant. Pain intensity, on a standard numerical scale, was significantly lower in the CST group than in the sham group (p<0.001). Disability scores, measuring how much neck pain affected daily function, also improved significantly. Both met the threshold for clinical relevance — the difference wasn't just detectable in a statistical sense, it was large enough to matter to patients.
For a small trial, these are clean results. The combination of a sham control, appropriate outcome measures, and clinically meaningful effect sizes makes this one of the stronger individual studies in the CST evidence base. Whether it would replicate in a larger trial is the natural follow-up question, and one that hasn't yet been fully answered.
Fibromyalgia: two trials, consistent direction
Fibromyalgia has been studied in two separate RCTs that together present a fairly consistent picture. The 2010 trial enrolled 92 patients — the larger of the two — and looked mainly at tender point count and pain intensity. Both showed significant improvements in the CST group compared to controls, and the results held at follow-up.
The 2011 trial focused on different outcomes: anxiety, depression, and overall quality of life, measured with validated scales. With 84 participants and a six-month follow-up, it captured something the earlier trial didn't — sustained effects over a longer period. The CST group showed significant improvements on anxiety, depression, and quality of life. Six months is longer follow-up than most manual therapy trials manage, which makes these results worth noting.
Fibromyalgia is a condition where patients often find conventional treatments only partly helpful. These trials don't establish CST as a first-line treatment, and they would benefit from replication in larger studies. But the direction across two independent trials, using different outcome measures and both finding benefit, is more consistent than much of the CST literature.
Pelvic girdle pain in pregnancy
The 2013 RCT on pregnancy-related pelvic girdle pain tells a more cautious story. The trial found that women in the CST group showed some improvement in pain and function compared to controls, but the researchers' own assessment was that the treatment effects were small and clinically questionable. That phrasing wasn't chosen to be encouraging.
This is a good example of the difference between a statistical trend and clinical meaningfulness. A study can detect a difference between groups that's real in a mathematical sense but too small to noticeably affect how patients feel or function. The pelvic girdle pain trial appears to fall into this category.
Pregnancy-related pain is an area where treatment options are limited by safety considerations, which makes the search for effective non-pharmacological approaches especially important. The CST trial here doesn't rule out any benefit, but it doesn't provide strong evidence of a clinically meaningful one either. For people in this situation, talking through the evidence with a practitioner and a midwife or obstetrician is the most reasonable approach.
These three conditions show the range of what CST research actually looks like: a strong small trial for neck pain, two consistent positive trials for fibromyalgia, and more limited results for pelvic girdle pain. Reading across them, rather than picking out the most favourable or least favourable result, gives the most accurate picture of where the evidence stands.